A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : Dsg / anti-desmoglein

[Related PubMed/MEDLINE]
Total Number of Papers: 37
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   Dsg  (>> Co-occurring Abbreviation)
Long Form:   anti-desmoglein
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris. AuAbs, Dsc3, MAPK, PV, SPCA1, SRC
2019 The relationship between pemphigus and systemic lupus erythematosus: a cross-sectional study, systematic review, and meta-analysis. SLE
2019 Translational Use of a Standardized Full Human Skin Organ Culture Model in Autoimmune Blistering Diseases. HSOC, PV, scFv
2018 Anti-Thyroid Peroxidase Reactivity Is Heightened in Pemphigus Vulgaris and Is Driven by Human Leukocyte Antigen Status and the Absence of Desmoglein Reactivity. A.R.s, AITD, anti-TPO, HLA, PV
2018 Clinical and immunological features of pemphigus relapse. mcPV, PF
2018 Increased risk of severe course of pemphigus in patients with pemphigus-associated alopecia: a prospective observational study. ---
2018 Regulatory effects of Nr4a2 on Th2 cells from patients with pemphigus vulgaris. ---
2017 Atypical Clinical and Serological Manifestation of Pemphigus Vegetans: A Case Report and Review of the Literature. Dsc, PVeg
2017 Correlation of antimuscarinic acetylcholine receptor antibody titers and antidesmoglein antibody titers with the severity of disease in patients with pemphigus. AChR
10  2017 Longitudinal Tracking of Autoantibody Levels in a Pemphigus Vulgaris Patient: Support for a Role of Anti-Desmoglein 1 Autoantibodies as Predictors of Disease Progression. PV
11  2016 Long-lasting Localized Pemphigus Vulgaris without Detectable Serum Autoantibodies Against Desmoglein 3 and Desmoglein 1. PSL, PV
12  2015 A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone. IFX, Ig, PV
13  2015 Anti-desmocollin autoantibodies in nonclassical pemphigus. cDNA, Dsc, ELISAs, Ig, PH, PNP, PVeg, RPs
14  2015 Correlation of conventional and conformational anti-desmoglein antibodies with phenotypes and disease activities in patients with pemphigus vulgaris. ELISA, PDAI
15  2015 Critical Role of the Neonatal Fc Receptor (FcRn) in the Pathogenic Action of Antimitochondrial Autoantibodies Synergizing with Anti-desmoglein Autoantibodies in Pemphigus Vulgaris. AMA, KCs, PV
16  2015 Detailed profiling of anti-desmoglein autoantibodies identifies anti-Dsg1 reactivity as a key driver of disease activity and clinical expression in pemphigus vulgaris. PV
17  2014 Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and appearance of anti-BP180 antibodies in the late stage of the disease. BO, BP, PNP
18  2013 A higher correlation of the antibody activities against the calcium-dependent epitopes of desmoglein 3 quantified by ethylenediaminetetraacetic acid-treated enzyme-linked immunosorbent assay with clinical disease activities of pemphigus vulgaris. EDTA, ELISA, PDAI, PV
19  2013 Are clinical phenotype and autoantibody profile always concordant in pemphigus? A study in a cohort of pemphigus patients. ---
20  2013 In vitro pathogenicity assay for anti-desmoglein autoantibodies in pemphigus. ---
21  2013 Targeted delivery of tumor necrosis factor-related apoptosis-inducing ligand to keratinocytes with a pemphigus mAb. GFP, TRAIL
22  2011 Catabolism of pemphigus foliaceus autoantibodies by high-dose IVIg therapy. HD-IVIg, PF
23  2011 Human leukocyte antigen genotypes and antibody profiles associated with familial pemphigus in Japanese. HLA, PF, PV
24  2011 Pregnancy-triggered maternal pemphigus vulgaris with persistent gingival lesions. PV
25  2011 Recalcitrant facial pemphigus vulgaris: correlation of skin lesions with the ratio of antidesmoglein antibodies 1 and 3. PV
26  2010 A prospective analysis of anti-desmoglein antibody profiles in patients with rheumatoid arthritis treated with thiol compounds. RA
27  2009 ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus. Ab, ELISA
28  2009 Simultaneous occurrence of anti-BP180 mucous membrane pemphigoid and mucosal-dominant pemphigus vulgaris. BP, MMP, PV
29  2009 [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide]. EIS
30  2007 Case of pemphigus foliaceus that shifted into pemphigus vulgaris after adrenal tumor resection. PF, PV
31  2007 IgG/IgA pemphigus with dyskeratotic acantholysis and intraepidermal neutrophilic microabscesses. ---
32  2007 Using desmoglein 1 and 3 enzyme-linked immunosorbent assay as an adjunct diagnostic tool for pemphigus. ELISA, PF, PV
33  2006 Paraneoplastic pemphigus mimicking erosive mucosal lichen planus associated with primary hepatocellular carcinoma. Ig, PNP
34  2005 Co-existence of pemphigus vulgaris and Hashimoto's thyroiditis. PV
35  2005 In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibodies in pemphigus vulgaris. IgG, mAb, PV
36  2001 Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus. PNP, PV
37  2000 Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity. AChR, PV